Effect of Timing of Gonadotropin-Releasing Hormone Agonist Administration for Ovarian Protection in Patients with Breast Cancer

PURPOSE: This study was performed to investigate the effect of the interval between the start of gonadotropin-releasing hormone agonist (GnRHa) and the start of chemotherapy on ovarian protection in patients with breast cancer. METHODS: This was a prospective observational cohort study that included...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Jae Jun, Choi, Young Min, Jun, Jong Kwan, Lee, Kyung-Hun, Kim, Tae-Yong, Han, Wonshik, Im, Seock-Ah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7311369/
https://www.ncbi.nlm.nih.gov/pubmed/32595989
http://dx.doi.org/10.4048/jbc.2020.23.e33

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7311369/
https://www.ncbi.nlm.nih.gov/pubmed/32595989
http://dx.doi.org/10.4048/jbc.2020.23.e33

Ejemplares similares